EUVIMEDEUVIMED entdecken
Übersichtsarbeit

How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection

Nicolas Cortes-Penfield iD, Martin Krsak, Laura Damioli, Michael Henry, Jessica Seidelman, Angela Hewlett, Laura Certain

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciad484 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Nicolas Cortes-Penfield und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA. Hauptthemen laut MEDLINE: Arthritis, Infectious, Prosthesis-Related Infections. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The optimal treatment of prosthetic joint infection (PJI) remains uncertain. Patients undergoing debridement, antibiotics, and implant retention (DAIR) receive extended antimicrobial treatment, and some experts leave patients at perceived highest risk of relapse on suppressive antibiotic therapy (SAT). In this narrative review, we synthesize the literature concerning the role of SAT to prevent treatment failure following DAIR, attempting to answer 3 key questions: (1) What factors identify patients at highest risk for treatment failure after DAIR (ie, patients with the greatest potential to benefit from SAT), (2) Does SAT reduce the rate of treatment failure after DAIR, and (3) What are the rates of treatment failure and adverse events necessitating treatment discontinuation in patients receiving SAT? We conclude by proposing risk–benefit stratification criteria to guide use of SAT after DAIR for PJI, informed by the limited available literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, InfectiousProsthesis-Related InfectionsHumansAnti-Bacterial AgentsTreatment OutcomeDebridementRetrospective StudiesTreatment Failure

Stichwörter der Autor:innen

DAIRPJIantibiotic suppressionprosthetic joint infectionsuppressive antibiotic therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Department of Medicine, Division of Infectious Diseases, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Department of Medicine, Division of Infectious Diseases, Hospital for Special Surgery, New York, New York, USA.
  • Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
  • Department of Orthopedic Surgery, University of Utah, Salt Lake City, Utah, USA.

ORCID-Profile: Nicolas Cortes-Penfield

Zitieren

APA

Cortes-Penfield, N., Krsak, M., Damioli, L., Henry, M., Seidelman, J., Hewlett, A., & Certain, L. (2024). How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad484

Vancouver

Cortes-Penfield N, Krsak M, Damioli L, Henry M, Seidelman J, Hewlett A, et al. How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad484

BibTeX
@article{CortesPenfield2024,
  author = {Cortes-Penfield, Nicolas and Krsak, Martin and Damioli, Laura and Henry, Michael and Seidelman, Jessica and Hewlett, Angela and Certain, Laura},
  title = {How We Approach Suppressive Antibiotic Therapy Following Debridement, Antibiotics, and Implant Retention for Prosthetic Joint Infection},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciad484}
}
Kostenlos starten →